Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.21
-$0.10-3.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.11M | -610.00K | -28.87M | -11.20M | -12.11M |
| Total Depreciation and Amortization | 926.00K | 1.46M | 1.46M | 1.47M | 984.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.20M | -12.89M | 16.49M | -994.00K | -1.14M |
| Change in Net Operating Assets | -2.07M | -1.46M | 3.05M | 2.39M | 585.00K |
| Cash from Operations | -14.05M | -13.50M | -7.87M | -8.35M | -11.68M |
| Capital Expenditure | -- | -11.00K | 0.00 | 0.00 | -15.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 60.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -11.00K | 60.00K | 0.00 | -15.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 49.05M | 10.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -414.00K | 2.24M | 2.43M | -- | -- |
| Cash from Financing | -414.00K | 51.29M | 2.44M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.46M | 37.78M | -5.37M | -8.35M | -11.70M |